Subscribe to Newsletter

Oncology

Inside the Lab Digital and computational pathology

A Real PAIGE-Turner

| Luke Turner

Paige.AI is developing deep learning algorithms to revolutionize cancer diagnostics

Diagnostics Hematology

Improving Our Early Warning System for AML

| Amanda Winters

The gold standard for monitoring acute myeloid leukemia relapse after bone marrow transplant is chimerism testing – but is it sensitive enough?

Subspecialties Oncology

TruSight™ Oncology 500: Enabling Comprehensive Genomic Profiling for Every Laboratory

| Sponsored by Illumina

Comprehensively exploring tumor samples to analyze hundreds of current and emerging cancer-related biomarkers

Outside the Lab Clinical care

The Integration Equation

| W. Dean Wallace, Robert Suh

Pathologists and radiologists must work closely together to provide the best possible patient care

Diagnostics Genetics and epigenetics

Circular RNA Makes Its Mark

| Jason Sherburn

A new detection method enhances circular RNA’s potential as a cancer biomarker and forms the basis of a new database

Diagnostics Digital and computational pathology

Biosensors for the Future

| Luke Turner

From a new material for lung cancer diagnosis to real-time robotics for monitoring reproductive hormones, discover our latest bite-sized breakthroughs

Subspecialties Biochemistry and molecular biology

Jagged Little Pill (for Cancer)

| Luke Turner

A Jagged protein directly linked to cancer metastasis could be targeted to assess the aggressiveness of tumors and prevent their rapid spread

Inside the Lab Clinical care

Positive Steps to Tackle Triple-Negative Breast Cancer

| Jane Armes

Jane Armes discusses the value of molecular subtyping and targeted therapies in triple-negative breast cancer

Inside the Lab Biochemistry and molecular biology

A Fluid Future

| Luke Turner

Liquid biopsy has shown promise as a rapid, minimally invasive way to profile tumors – but are commercially available tests accurate and consistent?

Diagnostics Liquid biopsy

A Diagnostic to Drool Over?

| Luke Turner

The use of saliva as a diagnostic fluid seems an attractive option – especially now that research reveals circulating tumor DNA in the fluid

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register